A Trial of Setmelanotide in Acquired Hypothalamic Obesity
Clinical trial NCT05774756 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05774756
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-26
- Primary completion
- 2025-03-18
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.